Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E P Lester

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
American Journal of Surgery|October 1, 1991
Concomitant cisplatin and hyperfractionated external beam irradiation for advanced malignancy of the head and neckJ Fontanesi, N S Beckford, E P Lester, et al.
The American Journal of Medicine|May 1, 1978
Sepsis in treated Hodgkin's diseaseE P Lester, R Chilcote, U Mintz, et al.
Cancer|February 1, 1997
Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer CenterI Athanasiadis, S Taylor, E E Vokes, et al.
Cancer Investigation|July 19, 2001
Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856E P Lester, G R Petroni, M Barcos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesisP J Hesketh, W K Murphy, E P Lester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomitingT M Beck, P J Hesketh, S Madajewicz, et al.
Cancer|July 1, 1979
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatmentU Mintz, J B Miller, H M Golomb, et al.
Annals of Internal Medicine|June 1, 1980
Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphomaD L Sweet, H M Golomb, J E Ultmann, et al.
Blood|June 1, 1977
Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerationsR K Desser, H M Golomb, J E Ultmann, et al.
Cancer|July 1, 1978
Non-Hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types: results of sequential staging procedures, response to therapy, and survival of 100 patientsJ D Bitran, H M Golomb, J E Ultmann, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
American Journal of Surgery|October 1, 1991
Concomitant cisplatin and hyperfractionated external beam irradiation for advanced malignancy of the head and neckJ Fontanesi, N S Beckford, E P Lester, et al.
The American Journal of Medicine|May 1, 1978
Sepsis in treated Hodgkin's diseaseE P Lester, R Chilcote, U Mintz, et al.
Cancer|February 1, 1997
Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer CenterI Athanasiadis, S Taylor, E E Vokes, et al.
Cancer Investigation|July 19, 2001
Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856E P Lester, G R Petroni, M Barcos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesisP J Hesketh, W K Murphy, E P Lester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomitingT M Beck, P J Hesketh, S Madajewicz, et al.
Cancer|July 1, 1979
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatmentU Mintz, J B Miller, H M Golomb, et al.
Annals of Internal Medicine|June 1, 1980
Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphomaD L Sweet, H M Golomb, J E Ultmann, et al.
Blood|June 1, 1977
Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerationsR K Desser, H M Golomb, J E Ultmann, et al.
Cancer|July 1, 1978
Non-Hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types: results of sequential staging procedures, response to therapy, and survival of 100 patientsJ D Bitran, H M Golomb, J E Ultmann, et al.
Pageof 6